Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132323) titled 'Effective dose of oliceridine combined with ciprofol for suppressing the response to gastroscope insertion' on Sept. 11.
Study Type: Interventional study
Study Design:
Dose comparison
Primary Sponsor: Jiaxing Second Hospital
Condition:
Oliceridine combined with ciprofol for suppressing the response to gastroscope insertion
Intervention:
Youth Group:Different doses of oliceridine
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-26
Target Sample Size: Youth Group:40;Middle-aged Group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sh...